S. Goncalves et al. / Tetrahedron 66 (2010) 7856e7860
7859
4.2.1. Methyl-3-oxo-2-(3-oxobutyl)-6-phenylhexanoate (7). Obtained
as a colourless oil (981 mg, 74%). Rf (98/2 CHCl3/MeOH)¼0.61. IR
1242, 1160, 1110, 1078, 1066, 823, 743, 703, 314, 505 cmꢀ1. 1H NMR:
¼7.64 (m, 4H), 7.36 (m, 6H), 3.70 (s, 3H), 3.64 (t, J¼6.4 Hz, 2H), 3.50
(t, J¼6.8 Hz, 1H), 2.45 (m, 4H), 2.04 (m, 5H), 1.64 (m, 2H), 1.51 (m,
2H), 1.05 (s, 9H) ppm. 13C NMR:
129.7, 127.8, 63.6, 57.3, 52.5, 41.9, 40.6, 31.9, 30.0, 27.0, 21.9, 20.1,
19.3 ppm. HRMS (ESI, m/z): calcd for C28H38O5Si [MþH]þ: 483.2567,
found: 483.2562.
d
(neat):
NMR:
n
¼2950, 1742, 1711, 1497, 1367, 1201, 1159, 748, 701 cmꢀ1. 1H
d
¼7.14 (m, 6H), 3.70 (s, 3H), 3.48 (t, J¼7.2 Hz,1H), 2.44 (m, 6H),
d
¼207.5, 204.9, 170.1, 135.6, 134.0,
2.02 (m, 5H), 1.84 (quint., J¼7.4 Hz, 2H) ppm. 13C NMR:
d¼207.6,
204.8, 170.1, 141.5, 128.6, 128.5, 126.1, 57.3, 52.5, 41.3, 40.6, 34.9, 30.0,
24.9, 21.9 ppm. HRMS (ESI, m/z): calcd for C17H22O4 [MþH]þ:
291.1596, found: 291.1591.
4.3. General procedure for the synthesis of C2-substituted
3-methylcyclohex-2-enones
4.2.2. Methyl 2-[3-(3-methylphenyl)propanoyl]-5-oxohexanoate (10).
Obtained as a yellow oil (3.48 g, 90%). Rf (95/5 CHCl3/MeOH)¼0.87. IR
(neat):
NMR:
n
¼2952, 1743, 1712, 1489,1435,1360, 1205, 1161, 782 cmꢀ1. 1H
DBU (0.243 mmol, 1.1 equiv) was added to a solution of
substituted the b-ketoester (0.221 mmol, 1.0 equiv) in acetonitrile
d
¼7.14 (t, J¼7.6 Hz, 1H), 6.96 (m, 3H), 3.67 (s, 3H), 3.49 (t,
J¼6.8 Hz, 1H), 2.78 (m, 4H), 2.39 (t, J¼6.8 Hz, 2H), 2.32 (s, 3H), 2.09 (s,
(5 mL, extra dry, water<10 ppm, AcroSealÒ) and the reaction
mixture was stirred under reflux for 3 h until completion. After
cooling the reaction media to room temperature and addition of
water (20 mL), the aqueous phase was extracted with diethyl ether
(3ꢂ10 mL). The combined organic extracts were dried over sodium
sulfate and evaporated in vacuo. The residue was purified by flash
chromatography on a silica gel column to give the desired
C2-susbtituted 3-methylcyclohex-2-enone.
3H), 2.03 (m, 2H) ppm. 13C NMR:
d¼207.5, 204.2, 169.9, 140.6, 138.1,
129.2, 128.5, 127.0, 125.4, 57.5, 52.5, 43.6, 40.4, 30.0, 29.5, 21.8,
21.4 ppm. HRMS (ESI, m/z): calcd for C17H22O4 [MþH]þ: 291.1596,
found: 291.1600.
4.2.3. Methyl 6-(3-isopropyl-2-methoxyphenyl)-3-oxo-2-(3oxo-bu-
tyl) hexanoate (12). Obtained as a yellow oil (1.42 g, 96%). Rf (95/5
CHCl3/MeOH)¼0.55. Data analysis of compound 12 can be found in
Ref. 7.
4.3.1. 3-Methyl-2-(2-phenylethyl)cyclohex-2-enone (9). Obtained from
7 (73 mg, 0.25 mmol) as a yellow oil (48 mg, 89%). Rf (70/30 cyclo-
4.2.4. Methyl-3-oxo-2-(3-oxobutyl)oct-7-enoate (14). Obtained as
a yellow oil (1.31 g, 66%). Rf (95/5 CHCl3/MeOH)¼0.76. IR (neat):
hexane/EtOAc)¼0.61. IR (neat):
1180,1138, 1033, 754, 702 cmꢀ1.1H NMR:
2.37 (t, J¼6.0 Hz, 2H), 2.28 (t, J¼6.0 Hz, 2H), 1.89 (quint., J¼6.0 Hz, 2H),
1.74 (s, 3H) ppm. 13C NMR:
n
¼2930, 1664, 1628, 1496, 1454, 1380,
d
¼7.15 (m, 5H), 2.55 (m, 4H),
n
¼2952, 1743, 1712, 1641, 1436, 1367, 1206, 1159, 998, 914 cmꢀ1. 1H
NMR:
d
¼5.69 (m, 1H), 4.95 (m, 2H), 3.70 (s, 3H), 3.50 (t, J¼7.2 Hz,
d
¼198.8, 156.2, 142.4, 134.8, 128.8, 128.3,
1H), 2.44 (m, 4H), 2.11 (s, 3H), 2.03 (m, 4H), 1.63 (quint., J¼7.2 Hz,
125.9, 38.1, 35.2, 32.9, 27.7, 22.4, 21.2 ppm. HRMS (ESI, m/z): calcd for
2H) ppm. 13C NMR:
d
¼207.5, 204.9, 170.1, 137.8, 115.4, 57.3, 52.5,
C15H18O [MþH]þ: 215.1436, found: 215.1432.
41.2, 40.6, 32.9, 30.0, 22.5, 21.9 ppm. HRMS (ESI, m/z): calcd for
C13H20O4 [MþH]þ: 258.1705, found: 258.1708.
4.3.2. 3-Methyl-2-(3-methylbenzyl)cyclohex-2-enone (11). Obtained
from 10 (3.44 g, 11.85 mmol) as a yellow oil (2.15 g, 85%). Rf (80/20
4.2.5. Methyl
Obtained as a yellow oil (2.18 g, 65%). Rf (95/5 CHCl3/MeOH)¼0.79.
IR (neat):
¼2955, 2929, 1744, 1713, 1435, 1409, 1367, 1204, 1159,
1066, 720 cmꢀ1. 1H NMR:
(7E)-3-oxo-2-(3-oxobutyl)dodec-7-enoate
(16).
cyclohexane/EtOAc)¼0.59. IR (neat):
n
¼2921, 2866, 1659, 1625, 1605,
1429, 1377, 1181, 1136, 958, 749, 693 cmꢀ1
.
1H NMR:
d
¼7.10 (t,
n
J¼7.6 Hz,1H), 6.93 (m, 3H), 3.65 (s, 2H), 2.42 (t, J¼5.6 Hz, 2H), 2.38 (t,
d
¼5.35 (m, 1H), 5.24 (m, 1H), 3.70 (s, 3H),
J¼6.0 Hz, 2H), 2.30 (s, 3H), 1.97 (s, 3H), 1.94 (m, 2H) ppm. 13C NMR:
3.50 (t, J¼7.2 Hz, 1H), 2.46 (m, 4H), 2.11 (s, 3H), 1.98 (m, 6H), 1.58
d
¼198.6, 157.0, 140.6, 137.8, 134.9, 129.2, 128.2, 126.5, 125.3, 37.9, 33.1,
(quint., J¼7.2 Hz, 2H), 1.28 (m, 4H), 0.86 (m, 3H) ppm. 13C NMR:
30.6, 22.3, 21.9, 21.5 ppm. HRMS (ESI, m/z): calcd for C15H18
O
d
¼207.5, 205.1, 170.1, 131.2, 128.5, 57.3, 52.5, 41.5, 40.6, 31.9, 30.0,
[MþH]þ, 215.1436, found: 215.1439.
27.1, 26.5, 23.5, 22.4, 21.9, 14.0 ppm. HRMS (ESI, m/z): calcd for
C17H28O4 [MþH]þ: 297.2066, found: 297.2062.
4.3.3. 2-[2-(3-Isopropyl-2-methoxyphenyl)ethyl]-3-methylcyclohex-
2-enone (13). Obtained from 12 (1.42 g, 3.92 mmol) as a yellow oil
(1.02 g, 90%). Rf (80/20 cyclohexane/EtOAc)¼0.59. Data analysis of
compound 13 can be found in Ref. 7.
4.2.6. Methyl 6-cyclohex-1-en-1-yl-3-oxo-2-(3-oxobutyl)hexanoate
(18). Obtained as a yellow oil (2.15 g, 85%). Rf (95/5 CHCl3/MeOH)¼
0.83. IR (neat):
n
¼2926, 2836, 1743, 1713, 1436, 1366, 1204, 1159,
1108, 1008, 918 cmꢀ1. 1H NMR:
J¼7.2 Hz, 1H), 2.40 (m, 4H), 2.12 (s, 3H), 2.04 (m, 2H), 1.87 (m, 7H),
1.49 (m, 7H) ppm. 13C NMR:
d
¼5.35 (m, 1H), 3.71 (s, 3H), 3.50 (t,
4.3.4. 2-But-3-enyl-3-methylcyclohex-2-enone (15). Obtained from
14 (1.28 g, 5.34 mmol) as a yellow oil (685 mg, 78%). Rf (70/30 cy-
clohexane/EtOAc)¼0.64. Data analysis of compound 15 can be
found in Ref. 4a.
d¼207.5, 205.1, 170.1, 136.8, 121.9, 57.4,
52.4, 41.5, 40.6, 37.4, 30.0, 28.1, 25.3, 23.0, 22.6, 21.9, 21.4 ppm.
HRMS (ESI, m/z): calcd for C17H26O4 [MþH]þ: 295.1909, found:
295.1912.
4.3.5. 3-Methyl-2-[(3E)-oct-3-en-1-yl]cyclohex-2-enone(17). Obtained
from 16 (2.15 g, 7.25 mmol) as a colourless oil (1.37 g, 86%). Rf (80/20
4.2.7. Methyl-3-oxo-2-(3-oxobutyl)oct-7-ynoate (20). Obtained as
a colourless oil (736 mg, 86%). Rf (95/5 CHCl3/MeOH)¼0.82. IR
cyclohexane/EtOAc)¼0.66. IR (neat):
1430, 1378, 1325, 1179, 1138, 1118, 1051, 725 cmꢀ1. 1H NMR:
2H), 2.30 (m, 6H), 1.96 (m, 4H), 1.88 (m, 5H), 1.27 (m, 4H), 0.86 (m,
3H) ppm. 13C NMR:
n
¼2926, 2860, 1662, 1628, 1455,
d
¼5.30 (m,
(neat):
n
¼3281, 2954, 1741, 1710, 1435, 1369, 1207, 1161, 1108,
649 cmꢀ1. 1H NMR:
d
¼3.71 (s, 3H), 3.52 (t, J¼7.2 Hz, 1H), 2.59 (m,
d
¼198.8, 155.4, 135.4, 130.4, 129.2, 38.0, 33.0, 32.1,
2H), 2.46 (t, J¼7.2 Hz, 2H), 2.19 (m, 2H), 2.11 (s, 3H), 2.05 (m, 2H),
27.0, 26.8, 25.4, 22.5, 22.4, 21.4, 14.1 ppm. HRMS (ESI, m/z): calcd for
1.94 (t, J¼2.8 Hz, 1H), 1.75 (quint., J¼7.2 Hz, 2H) ppm. 13C NMR:
C15H24O [MþH]þ: 221.1905, found: 221.1902.
d
¼207.5, 204.5, 170.0, 83.4, 69.3, 57.4, 52.5, 40.5, 40.4, 30.0, 22.0,
21.9, 17.6 ppm. HRMS (ESI, m/z): calcd for C13H18O4 [MþH]þ:
4.3.6. 2-(2-Cyclohex-1-enylethyl)-3-methylcyclohex-2-enone
(19). Obtained from 18 (2.07 g, 7.04 mmol) as a yellow liquid
(1.12 g, 73%). Rf (80/20 cyclohexane/EtOAc)¼0.68. IR (neat):
239.1283, found: 239.1280.
4.2.8. Methyl 7-{[tert-butyl(diphenyl)silyl]oxy}-3-oxo-2-(3-oxobutyl)
heptanoate (22). Obtained as a yellow oil (2.36 g, 85%). Rf (95/5
n
¼2926, 2836, 1743, 1713, 1436, 1366, 1204, 1159, 1108, 1008,
918 cmꢀ1. 1H NMR:
d
¼5.35 (m, 1H), 2.29 (m, 6H), 1.80 (m, 12H), 1.55
¼198.7, 155.1, 137.8, 135.6,
CHCl3/MeOH)¼0.57. IR (neat):
n
¼2958, 2901, 1745, 1716, 1428, 1393,
(m, 2H), 1.50 (m, 2H) ppm. 13C NMR:
d